Cholangitis
Clinical trials for Cholangitis explained in plain language.
Never miss a new study
Get alerted when new Cholangitis trials appear
Sign up with your email to follow new studies for Cholangitis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new drug rescue the liver when standard therapy fails?
Disease control CompletedThis phase 2 trial is testing an experimental drug called HTD1801 (BUDCA) in adults with primary biliary cholangitis (PBC) who haven't responded adequately to standard treatment. The goal is to see if the drug can safely lower alkaline phosphatase (ALP) levels, a key marker of li…
Matched conditions: CHOLANGITIS
Phase 2 • Sponsor: HighTide Therapeutics (Hong Kong) Limited • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Could one day of antibiotics be enough for bile duct infections?
Disease control CompletedThis study looked at 410 patients with a bile duct infection (cholangitis) who had a procedure to drain the bile duct. It compared giving antibiotics for just 1 day versus the usual 4 to 7 days. The goal was to see if the shorter course is just as good at curing the infection, wh…
Matched conditions: CHOLANGITIS
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Disposable scope could cut infection risk in ERCP
Knowledge-focused CompletedThis study tested a new single-use duodenoscope (aScope) in 59 patients at high risk of infection after ERCP, a procedure to treat bile duct problems. The goal was to see if the scope works well and to gather information on costs and complications. The results could help decide i…
Matched conditions: CHOLANGITIS
Sponsor: Nottingham University Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC